Evidence map›Paper›PMID 37208144›Full record

Observational studyBMJ open2023

Evaluating use of mass-media communication intervention 'MTV-Shuga' on increased awareness and demand for HIV and sexual health services by adolescent girls and young women in South Africa: an observational study.

Natsayi Chimbindi, Nondumiso Mthiyane, Glory Chidumwa, Thembelihle Zuma, Jaco Dreyer, Isolde Birdthistle, Sian Floyd, Nambusi Kyegombe, Chris Grundy, Cherie Cawood and 7 more

Abstract readObservational Study
In one paragraph

Observational study in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Natsayi ChimbindiAfrica Health Research Institute, KwaZulu-Natal, South Africa.ORCID 0000-0003-3125-978X
Nondumiso MthiyaneAfrica Health Research Institute, KwaZulu-Natal, South Africa.ORCID 0000-0002-9881-7267
Glory ChidumwaAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Thembelihle ZumaAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Jaco DreyerAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Isolde BirdthistleDepartment of Population Health, London School of Hygiene and Tropical Medicine Faculty of Epidemiology and Population Health, London, UK.ORCID 0000-0001-5742-6588
Sian FloydInfectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.ORCID 0000-0002-8615-7601
Nambusi KyegombeMRC Uganda Virus Research Institute, London School of Hygiene & Tropical Medicine, London, UK.
Chris GrundyDepartment of Population Health, London School of Hygiene and Tropical Medicine Faculty of Epidemiology and Population Health, London, UK.
Cherie CawoodEpicentre Health Research, Durban, South Africa.
Siva DanaviahAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Theresa SmitAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Deenan PillayInfection and Immunity, University College London, London, UK.
Kathy BaisleyAfrica Health Research Institute, KwaZulu-Natal, South Africa.
Guy HarlingAfrica Health Research Institute, KwaZulu-Natal, South Africa.ORCID 0000-0001-6604-491X
Janet SeeleyAfrica Health Research Institute, KwaZulu-Natal, South Africa.ORCID 0000-0002-0583-5272
Maryam ShahmaneshAfrica Health Research Institute, KwaZulu-Natal, South Africa m.shahmanesh@ucl.ac.uk.

Funding

Maximizing combination HIV prevention, uptake and retention by adolescent girls and young womenR01MH114560 · NIMH · KWAZULU-NATAL RESEARCH INSTITUTE TB-HIV · PI SHAHMANESH, MARYAM · 2017 to 2023
$2.0M
Department of HealthMedical Research Council MR/R010161/1NIMH NIH HHS R01 MH114560Wellcome TrustWellcome Trust 201433/Z/16/AWellcome Trust 210479/Z/18/ZWellcome Trust 224309/Z/21/Z
6 · The paper itself

Abstract

objectiveTo investigate the effect of exposure to MTV Shuga:Down South' (MTVShuga-DS) during the scale-up of combination HIV-prevention interventions on awareness and uptake of sexual reproductive health (SRH) and HIV-prevention services by adolescent girls and young women (AGYW).

designOne longitudinal and three cross-sectional surveys of representative samples of AGYW.

settingAGYW in four South African districts with high HIV prevalence (>10%) (May 2017 and September 2019).

participants6311 AGYW aged 12-24. MEASURES: Using logistic regression, we measured the relationship between exposure to MTV Shuga-DS and awareness of pre-exposure prophylaxis (PrEP), condom use at last sex, uptake of HIV-testing or contraception, and incident pregnancy or herpes simplex virus 2 (HSV-2) infection.

resultsWithin the rural cohort 2184 (85.5%) of eligible sampled individuals were enrolled, of whom 92.6% had at least one follow-up visit; the urban cross-sectional surveys enrolled 4127 (22.6%) of eligible sampled individuals. Self-report of watching at least one MTV Shuga-DS episode was 14.1% (cohort) and 35.8% (cross-section), while storyline recall was 5.5% (cohort) and 6.7% (cross-section). In the cohort, after adjustment (for HIV-prevention intervention-exposure, age, education, socioeconomic status), MTVShuga-DS exposure was associated with increased PrEP awareness (adjusted OR (aOR) 2.06, 95% CI 1.57 to 2.70), contraception uptake (aOR 2.08, 95% CI 1.45 to 2.98) and consistent condom use (aOR 1.84, 95% CI 1.24 to 2.93), but not with HIV testing (aOR 1.02, 95% CI 0.77 to 1.21) or acquiring HSV-2 (aOR 0.92, 95% CI 0.61 to 1.38). In the cross-sections, MTVShuga-DS was associated with greater PrEP awareness (aOR 1.7, 95% CI 1.20 to 2.43), but no other outcome.

conclusionsAmong both urban and rural AGYW in South Africa, MTVShuga-DS exposure was associated with increased PrEP awareness and improved demand for some HIV prevention and SRH technologies but not sexual health outcomes. However, exposure to MTVShuga-DS was low. Given these positive indications, supportive programming may be required to raise exposure and allow future evaluation of edu-drama impact in this setting.

Indexed as

HIV InfectionsPre-Exposure ProphylaxisAdolescentCommunicationCross-Sectional StudiesFemaleHumansPregnancySexual BehaviorSouth AfricaHIV & AIDSpreventive medicinepublic health

Identifiers

PMID37208144
PMCPMC10201230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.